home.social

Search

206 results for “KirstieJane”

  1. Absolutely honoured to listen to Deborah Udon who is speaking as part of the plenary session at . She’s sharing how she bridged her passion for through contributions, particularly through her work with we-are-ols.org/community.html

  2. @KirstieJane whilst people may actually be remote, it's clear that not all work practices have adjusted themselves. We totally do not have #asyncWork working. I think #asyncWork rather than just #remoteFirst is the true goal. Then we each can work/engage when circumstances allow.

  3. Oooph, the exclusion of in-person only networking and strategy setting events is making me furious.

    Baby is poorly, I’m poorly, so the responsible thing is to stay home tomorrow. To not pass on my germs to 20+ colleagues.

    And therefore I’ll miss the (an? feels like the) opportunity to shape the direction of a major research initiative and (possibly) gain some respect as a fellow research leader.

    I’m so mad that we’ve let drop by the wayside so badly 😭🤬🤦🏼‍♀️

  4. I don’t love for all the reasons that Nina Tame shares on instagram (check out her post at instagram.com/p/DCUhO4GM39j/, and her website at ninatame.komi.io) - in short: children shouldn’t have to share their personal circumstances, difficulties and trauma to be deserving of support and access. That’s what a government should provide.

    BUT I do love a nursery bake sale! Look at these amazing made by Mackenzie’s favourite staff member!

  5. There are multiple dimensions of challenge if you live with and we are now turning to a deep dive into one of them: - taking multiple medications for those multiple conditions.

    We’re honoured to have Prof Tony Avery who is the National Clinical Director for Prescribing for NHS England chair the discussion and present an introduction including recommendations for systematic and cultural improvements within the NHS.

  6. “The programme is ahead of other areas in in thinking about the benefits of collaboration to solve real world problems.”

    “Early career researchers are our leaders of tomorrow. We must invest in their success by providing career pathways for research in multiple long term conditions

    A fantastic interview of Professor Lucy Chappell, Chief Scientific Adviser to the Department of Health & Social Care & CEO of .

  7. Really delighted to hear from MP Chi Onwurah, Chair of the Science, Innovation and Technology Select Committee. She’s speaking on how can deliver !

    Read all about her at en.m.wikipedia.org/wiki/Chi_On

  8. “The #AIM programme is ahead of other areas in #HealthDataScience in thinking about the benefits of #interdisciplinary collaboration to solve real world problems.”

    “Early career researchers #ECRs are our leaders of tomorrow. We must invest in their success by providing career pathways for research in multiple long term conditions #MLTC

    A fantastic interview of Professor Lucy Chappell, Chief Scientific Adviser to the Department of Health & Social Care #DHSX & CEO of #NIHR.

    #PioneerAIM #AIMRSF

  9. “The #AIM programme is ahead of other areas in #HealthDataScience in thinking about the benefits of #interdisciplinary collaboration to solve real world problems.”

    “Early career researchers #ECRs are our leaders of tomorrow. We must invest in their success by providing career pathways for research in multiple long term conditions #MLTC

    A fantastic interview of Professor Lucy Chappell, Chief Scientific Adviser to the Department of Health & Social Care #DHSX & CEO of #NIHR.

    #PioneerAIM #AIMRSF

  10. “The #AIM programme is ahead of other areas in #HealthDataScience in thinking about the benefits of #interdisciplinary collaboration to solve real world problems.”

    “Early career researchers #ECRs are our leaders of tomorrow. We must invest in their success by providing career pathways for research in multiple long term conditions #MLTC

    A fantastic interview of Professor Lucy Chappell, Chief Scientific Adviser to the Department of Health & Social Care #DHSX & CEO of #NIHR.

    #PioneerAIM #AIMRSF

  11. “The #AIM programme is ahead of other areas in #HealthDataScience in thinking about the benefits of #interdisciplinary collaboration to solve real world problems.”

    “Early career researchers #ECRs are our leaders of tomorrow. We must invest in their success by providing career pathways for research in multiple long term conditions #MLTC

    A fantastic interview of Professor Lucy Chappell, Chief Scientific Adviser to the Department of Health & Social Care #DHSX & CEO of #NIHR.

    #PioneerAIM #AIMRSF

  12. As part of the discussion Prof Avery has invited Alan Griffiths - who has multiple long term conditions and who takes 14 pills per day. He talks about how these define him (or not) and which elements are the most challenging.

    “It’s not the conditions that are the hardest part, it’s what I have to do to manage all of them, every day. Especially through some of the hardest times in my life.”

    #PioneerAIM #AIMRSF #MLTC

  13. As part of the discussion Prof Avery has invited Alan Griffiths - who has multiple long term conditions and who takes 14 pills per day. He talks about how these define him (or not) and which elements are the most challenging.

    “It’s not the conditions that are the hardest part, it’s what I have to do to manage all of them, every day. Especially through some of the hardest times in my life.”

  14. As part of the discussion Prof Avery has invited Alan Griffiths - who has multiple long term conditions and who takes 14 pills per day. He talks about how these define him (or not) and which elements are the most challenging.

    “It’s not the conditions that are the hardest part, it’s what I have to do to manage all of them, every day. Especially through some of the hardest times in my life.”

    #PioneerAIM #AIMRSF #MLTC

  15. As part of the discussion Prof Avery has invited Alan Griffiths - who has multiple long term conditions and who takes 14 pills per day. He talks about how these define him (or not) and which elements are the most challenging.

    “It’s not the conditions that are the hardest part, it’s what I have to do to manage all of them, every day. Especially through some of the hardest times in my life.”

    #PioneerAIM #AIMRSF #MLTC

  16. As part of the discussion Prof Avery has invited Alan Griffiths - who has multiple long term conditions and who takes 14 pills per day. He talks about how these define him (or not) and which elements are the most challenging.

    “It’s not the conditions that are the hardest part, it’s what I have to do to manage all of them, every day. Especially through some of the hardest times in my life.”

    #PioneerAIM #AIMRSF #MLTC

  17. Our last speaker in this session is Krish Nirantharakumar Co-PI Optimal at the University of Birmingham. His talk is focused on Utilising an informatics consult to improve prescribing.

    His team are building tools to visualise and analyse the prescribing of multiple long term conditions. The tool can also start to predict what conditions might emerge over time!

    #PioneerAIM #AIMRSF #MLTC

  18. Our last speaker in this session is Krish Nirantharakumar Co-PI Optimal at the University of Birmingham. His talk is focused on Utilising an informatics consult to improve prescribing.

    His team are building tools to visualise and analyse the prescribing of multiple long term conditions. The tool can also start to predict what conditions might emerge over time!

  19. Our last speaker in this session is Krish Nirantharakumar Co-PI Optimal at the University of Birmingham. His talk is focused on Utilising an informatics consult to improve prescribing.

    His team are building tools to visualise and analyse the prescribing of multiple long term conditions. The tool can also start to predict what conditions might emerge over time!

    #PioneerAIM #AIMRSF #MLTC

  20. Our last speaker in this session is Krish Nirantharakumar Co-PI Optimal at the University of Birmingham. His talk is focused on Utilising an informatics consult to improve prescribing.

    His team are building tools to visualise and analyse the prescribing of multiple long term conditions. The tool can also start to predict what conditions might emerge over time!

    #PioneerAIM #AIMRSF #MLTC

  21. Our last speaker in this session is Krish Nirantharakumar Co-PI Optimal at the University of Birmingham. His talk is focused on Utilising an informatics consult to improve prescribing.

    His team are building tools to visualise and analyse the prescribing of multiple long term conditions. The tool can also start to predict what conditions might emerge over time!

    #PioneerAIM #AIMRSF #MLTC

  22. Mike Barnes of Queen Mary University is having us ponder even how you define something like a “long term prescription”? What is long? What if someone switches medications? How long a gap is enough to note?

    The AI-Multiply team are taking a longitudinal approach and using #AI and data science tools to follow prescribing data over time for individuals and then summarising them across cohorts.

    #PioneerAIM #AIMRSF #MLTC

  23. Mike Barnes of Queen Mary University is having us ponder even how you define something like a “long term prescription”? What is long? What if someone switches medications? How long a gap is enough to note?

    The AI-Multiply team are taking a longitudinal approach and using and data science tools to follow prescribing data over time for individuals and then summarising them across cohorts.

  24. Mike Barnes of Queen Mary University is having us ponder even how you define something like a “long term prescription”? What is long? What if someone switches medications? How long a gap is enough to note?

    The AI-Multiply team are taking a longitudinal approach and using #AI and data science tools to follow prescribing data over time for individuals and then summarising them across cohorts.

    #PioneerAIM #AIMRSF #MLTC

  25. Mike Barnes of Queen Mary University is having us ponder even how you define something like a “long term prescription”? What is long? What if someone switches medications? How long a gap is enough to note?

    The AI-Multiply team are taking a longitudinal approach and using #AI and data science tools to follow prescribing data over time for individuals and then summarising them across cohorts.

    #PioneerAIM #AIMRSF #MLTC

  26. Mike Barnes of Queen Mary University is having us ponder even how you define something like a “long term prescription”? What is long? What if someone switches medications? How long a gap is enough to note?

    The AI-Multiply team are taking a longitudinal approach and using #AI and data science tools to follow prescribing data over time for individuals and then summarising them across cohorts.

    #PioneerAIM #AIMRSF #MLTC

  27. Our next speaker Lauren Walker, Co-PI DynAIRx is presenting on “Using real world data to identify and plan interventions to minimise polypharmacy and transform prescribing in multiple long term conditions”

    The team have been engaging with clinicians to ask what AI tools would be useful for them? They all emphasised the importance of transparency in how any tool makes its recommendation / decision.

    #PioneerAIM #AIMRSF #MLTC

  28. Our next speaker Lauren Walker, Co-PI DynAIRx is presenting on “Using real world data to identify and plan interventions to minimise polypharmacy and transform prescribing in multiple long term conditions”

    The team have been engaging with clinicians to ask what AI tools would be useful for them? They all emphasised the importance of transparency in how any tool makes its recommendation / decision.

  29. Our next speaker Lauren Walker, Co-PI DynAIRx is presenting on “Using real world data to identify and plan interventions to minimise polypharmacy and transform prescribing in multiple long term conditions”

    The team have been engaging with clinicians to ask what AI tools would be useful for them? They all emphasised the importance of transparency in how any tool makes its recommendation / decision.

    #PioneerAIM #AIMRSF #MLTC

  30. Our next speaker Lauren Walker, Co-PI DynAIRx is presenting on “Using real world data to identify and plan interventions to minimise polypharmacy and transform prescribing in multiple long term conditions”

    The team have been engaging with clinicians to ask what AI tools would be useful for them? They all emphasised the importance of transparency in how any tool makes its recommendation / decision.

    #PioneerAIM #AIMRSF #MLTC